Replimune closes $155.8M public offering of stock and pre-funded warrants

Replimune Group, Inc.

Offering of 6,923,000 common shares at $13.00 and 3,846,184 pre-funded warrants at $12.9999 each, raising ~$155.8M net.
Underwriter's over-allotment option for 1,615,377 additional shares exercised in full.
Pre-funded warrants have $0.0001 exercise price; beneficial ownership cap corrected to 19.99% in this amendment.
Shares and warrants sold pursuant to effective shelf registration; expected closing Nov 27 and Dec 4, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.